Dr Frankel was recently featured on Paxton Quigley's radio show, "Cannabis Healing", to talk about cannabis and it's use for end of life/palliative care.
My first clinical experiences with Cannabidiol (CBD) and Type II Diabetes were generally with patients who were on Metformin. Within a couple of days of starting CBD the patients had a tendency to become hypoglycemic. After consultation with me and their primary care doctor, working together, most of these early patients ended up stopping their Metformin and continuing with cannabidiol. Generally, over the next six months, most of these patients had lower Hemoglobin A1C.
Now I see patients who come in specifically to help their Diabetes. It is of course not just for glucose control. It is for treatment of their neuropathy and obesity. There are some early studies, with links at end of this article, showing retinal protection may also be a real benefit. As diabetes is such a multi system disease, adding CBD along with the patients’ other regimens can only be helpful.
We are just talking about a plant extract that is highly neuro protective, often normalizes serum glucose and helps the patient lose weight.
Not much to lose. These should keep you busy:
https://www.ncbi.nlm.nih.gov/pubmed/?term=diabetes+cannabidiol
https://www.ncbi.nlm.nih.gov/pubmed/?term=glucose+cannabidiol
You Might Also Enjoy...
Dr Frankel was recently featured on Paxton Quigley's radio show, "Cannabis Healing", to talk about cannabis and it's use for end of life/palliative care.
There has been mentioned regarding potential risk of using THC for hormonally sensitive cancers. The article mentioned below I believe settles the issue
Potential future use of THC-V for parkinson's disease and Essential Tremor
Hemp and Cannabis are becoming more complex and it is critical to know the differences
This article covers the various aspects of cancer care involving the use of Medical Cannabis
When we think of the “Placebo Effect” we think of an effect that is “imagined”.